Yongfei Wang

2.8k citations
70 papers · 1.3k indexed · h-index 18
Topics
Pituitary Gland Disorders and Treatments (44 papers)Growth Hormone and Insulin-like Growth Factors (20 papers)Glioma Diagnosis and Treatment (15 papers)
Partner nations
ChinaUnited StatesPoland

In The Last Decade

Yongfei Wang

65 papers receiving 1.3k citations

Peers

Yongfei Wang
Comparison fields: 5 of 109
  • Endocrinology, Diabetes and Metabolism 866
  • Surgery 310
  • Molecular Biology 301
  • Cardiology and Cardiovascular Medicine 225
  • Epidemiology 210
Replace Lin Lü with:
Lin Lü China
Liwen Li China
Timo Deutschbein Germany
Entela Bollano Sweden
Chengchun Tang China
A Ram Hong South Korea
Masashi Fujita Japan
Ahmed Saad United States
Maria Sambataro Italy
Takako Nagai Japan
Yongfei Wang relative to Lin Lü China Lin Lü's profile →
Citations per field
00.5×
Lin Lü · 1×
Citations per year

Countries citing papers authored by Yongfei Wang

Since Specialization
Citations

This map shows the geographic impact of Yongfei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongfei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongfei Wang more than expected).

Fields of papers citing papers by Yongfei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yongfei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongfei Wang. The network helps show where Yongfei Wang may publish in the future.

Co-authorship network of co-authors of Yongfei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Yongfei Wang. A scholar is included among the top collaborators of Yongfei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yongfei Wang. Yongfei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 1
5 6
6 1
7 3
8 9
9 6
10 31
11 7
12 13
13 10
14 9
15 16
16 6
17 29
18 9
19 3
20 24

About Yongfei Wang

Yongfei Wang is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Ophthalmology, having authored 70 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (44 papers), Growth Hormone and Insulin-like Growth Factors (20 papers) and Glioma Diagnosis and Treatment (15 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (866 citations), Genetics (163 citations) and Cardiology and Cardiovascular Medicine (225 citations). Yongfei Wang has collaborated with scholars based in China, United States and Poland. Frequent co-authors include Harlan M. Krumholz, Silvio E. Inzucchi, JoAnne M. Foody, Edward P. Havranek, Frederick A. Masoudi, Yao Zhao, Xuefei Shou, Zhaoyun Zhang, Shiqi Li and Ming Shen. Their work appears in journals such as JAMA, Circulation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026